TScan Therapeutics Inc. (TCRX)
NASDAQ: TCRX
· Real-Time Price · USD
1.83
0.02 (1.10%)
At close: Aug 15, 2025, 2:35 PM
TScan Therapeutics Cash Flow Statement
Financials in USD. Fiscal
year is
January - December.
| Fiscal Year | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 | Q3 2021 | Q2 2021 | Q1 2021 |
| Period Ending | Jun 30, 2025 | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 |
Net Income | -136.78M | -131.48M | -127.5M | -111.3M | -104.41M | -96.8M | -89.22M | -88.33M | -81.58M | -72.63M | -66.22M | -61.7M | -61.29M | -56.87M | -48.63M | -42.23M | -33.56M | -28.5M |
Depreciation & Amortization | 3.11M | 3.53M | 4.11M | 4.68M | 4.94M | 5.12M | 5.36M | 5.57M | 5.53M | 5.44M | 5.14M | 4.79M | 4.6M | 4.05M | 3.33M | 2.58M | 1.87M | 1.48M |
Stock-Based Compensation | 11.92M | 10.98M | 9.55M | 8.34M | 7.15M | 6.04M | 5.21M | 5M | 4.91M | 4.71M | 4.55M | 4.04M | 3.68M | 3.16M | 2.52M | 1.88M | 1.13M | 748K |
Other Working Capital | 2.97M | -2.18M | 3.06M | -6.77M | 23.2M | 20.34M | 17.66M | 22.52M | -8.43M | -8.26M | -10.85M | -9.8M | -8.14M | -9.86M | -5.91M | -6.41M | -5.45M | 17.6M |
Other Non-Cash Items | -9.43M | -2.95M | 2.87M | 7.12M | 8.65M | 9.05M | 4.62M | 871K | -2.66M | 148K | 2.48M | -3.63M | 1.8M | -834K | -2.26M | 3.63M | 1.89M | 21.53M |
Deferred Income Tax | n/a | n/a | n/a | -4.7M | -4.94M | -4.94M | -4.94M | -235K | n/a | n/a | n/a | 5.9M | 5.9M | 5.9M | 5.9M | n/a | n/a | n/a |
Change in Working Capital | 4.98M | 779K | 5.05M | -6.4M | 22.27M | 19.38M | 17.61M | 23.52M | -8.18M | -7.97M | -10.23M | -12.05M | -8.5M | -9.19M | -5.9M | -3.88M | -3.23M | 18.42M |
Operating Cash Flow | -126.18M | -119.14M | -110.82M | -107.18M | -71.24M | -67.04M | -61.36M | -53.6M | -78.62M | -69.97M | -66.5M | -64.87M | -61.51M | -58.84M | -48.68M | -41.65M | -33.8M | -7.85M |
Capital Expenditures | -5.07M | -4.65M | -3.83M | -3.41M | -3.46M | -3.01M | -3.15M | -4.05M | -3.06M | -4.53M | -4.22M | -5.06M | -5.49M | -7.51M | -9.94M | -9.12M | -9.61M | -6.01M |
Cash Acquisitions | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Purchase of Investments | -271.78M | -293.6M | -241.44M | -211.73M | -134.75M | -86.39M | -77.61M | -59.99M | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Sales Maturities Of Investments | 283.76M | 223.01M | 192.66M | 137.15M | 81.15M | 65.65M | 20M | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Other Investing Acitivies | n/a | n/a | 36.87M | 39.25M | -20.75M | -20.75M | -57.61M | -59.99M | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Investing Cash Flow | 6.91M | -75.25M | -52.61M | -77.99M | -57.05M | -23.76M | -60.76M | -64.05M | -3.06M | -4.53M | -4.22M | -5.06M | -5.49M | -7.51M | -9.94M | -9.12M | -9.61M | -6.01M |
Debt Repayment | 15.31M | 15.31M | 15.31M | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Common Stock Repurchased | 191K | n/a | n/a | 176K | 176K | 176K | 176K | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Dividend Paid | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Other Financial Acitivies | -409K | 161.06M | 161.84M | 161.86M | 161.8M | 135.89M | 135.63M | 135.72M | 164.91M | 29.27M | 29.36M | 29.37M | 90.85M | 90.13M | 89.94M | 89.86M | -749K | -37K |
Financial Cash Flow | 46.51M | 207.98M | 208.76M | 163.09M | 161.61M | 135.7M | 135.44M | 135.53M | 164.91M | 29.27M | 29.36M | 29.37M | 90.85M | 90.13M | 189.67M | 189.59M | 98.98M | 99.69M |
Net Cash Flow | -72.77M | 13.6M | 45.33M | -22.07M | 33.32M | 44.91M | 13.33M | 17.88M | 83.23M | -45.23M | -41.37M | -40.56M | 23.85M | 23.77M | 131.05M | 138.83M | 55.58M | 85.83M |
Free Cash Flow | -131.25M | -123.79M | -114.65M | -110.58M | -74.7M | -70.05M | -64.5M | -57.66M | -81.68M | -74.5M | -70.73M | -69.93M | -67M | -66.36M | -58.62M | -50.76M | -43.4M | -13.86M |